Introduction
It is evident that Helicobacter pylori infection is related to several digestive diseases, including stomach cancer [1] [2] [3] . Acquisition of infection seems to occur primarily in childhood through the oral-oral or fecal-oral route, mainly from the family [4] [5] [6] . There is no doubt that environmental factors, especially sanitary conditions, determine the infection rate in the population. However, some individuals do not develop persistent infection even under the same poor sanitary condition, suggesting that host factors play a role in the infection and its maintenance. In addition, a twin study demonstrated that monozygous twins had a higher concordant rate of H. pylori infection than dizygous twins [7] , indicating the importance of genetic traits.
Until recently, the information on genetic factors of the host and H. pylori infection was very limited; only HLA genotype and ABO blood type had been examined in relation to H. pylori infection [8] [9] [10] . In the past year, significant associations between H. pylori seropositivity and DNA sequence variants of the host were reported for the following genes; secretor (Se or FUT2) and Lewis (Le or FUT3) [11] , interleukin 1B (IL-1B) [12, 13] , myeloperoxidase (MPO) [14] , and tumor necrosis factor-A (TNF-A) [15] . The Se and Le genes encode the enzymes related to the synthesis of H type I (type O substance of ABO blood type) and Lewis b (Le b ) antigens, respectively. These gene products are the ligands for blood-group antigen-binding adhesin (BabA) of H. pylori. The other three genes encode proinflammatory cytokines and enzymes, which could be attributed to a condition of the persistent H. pylori infection.
Concerning Se and Le polymorphisms, the biological background for the significant association seems clear. BabA on the surface of the H. pylori membrane combines H type I and Le b expressed on the gastric epithe-lial cells [16] [17] [18] . The attachment of H. pylori to the epithelium causes a series of pathogenic processes in the gastric mucosa [19] . H type I is synthesized from the precursor by the Se enzyme, and then converted to Le b by the Le enzyme. The Le enzyme also metabolizes the precursor of H type I to Lewis a (Le a ) antigen [20] . Low activity of Se enzyme and high activity of Le enzyme is considered to prevent the synthesis of H type I and Le b , which may result in a reduced chance of H. pylori infection. It has been demonstrated that the sej and se5 alleles of the Se gene and the le1 and le2 alleles of the Le gene have negligible or no functional activity [21] [22] [23] . In a previous study [11] , we reported that low seropositivity of anti-H. pylori IgG antibody was associated with low expression alleles of Se and high expression alleles of Le.
Consistency, defined as the repeated observation of an association in different populations under different circumstances, is one of the criteria for establishing a causal association. It is not uncommon that epidemiologic studies of genetic polymorphisms show inconsistent results, possibly due to effect modification by genetic background and/or lifestyle. Therefore, we conducted confirmatory studies to examine whether the previously observed association of Se and Le genotypes with H. pylori seropositivity [11] could be replicated in different study populations.
Subjects and methods

Study subjects
The subjects were sampled from first-visit outpatients of Aichi Cancer Center Hospital who participated in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center -II (HERPACC-II) [24] in 2001, and from health checkup examinees who received a health checkup provided by Nagoya Municipal Government in 2000.
At the Aichi Cancer Center Hospital, approximately 20% of first-visit outpatients had a cancer, and about 60% of the first-visit outpatients donated 7 ml of peripheral blood after they had provided written informed consent for genetic polymorphism research [24] . The population enrolled in the study consisted of 679 firstvisit outpatients who agreed to the blood donation (FVO group).
The other subject group consisted of residents of a western part of Nagoya City. Written informed consent for anonymous use of the residual blood for research purposes was obtained after blood was drawn for a health checkup. Typically, about 2 ml of blood was left after the routine tests for health checkup. Of 489 examinees invited to participate in the study, 468 (95.7%) agreed to provide their residual blood for genotyping and other laboratory assays. Residual blood samples from 3 subjects were not available for DNA extraction [25] . The remaining 465 health checkup examinees (HCE group) were included in this study.
Laboratory tests
Peripheral blood of the FVO subjects at Aichi Cancer Center Hospital was separated into buffy coat and plasma on the day of blood sampling. The residual blood of the HCE subjects was similarly separated, 3 days after blood sampling. The buffy coat and plasma were stored at Ϫ40°C after the separation. DNA was extracted from the buffy coat with a QIAamp DNA Blood Mini Kit (QIAGEN, Valencia, CA, USA). The plasma was used for an anti-H. pylori IgG antibody test ("HM-CAP", Enteric Products, Westbury, NY, USA). An enzyme-linked immunosorbent assay (ELISA) value of 2.3 or over was regarded as H. pylori infectionpositive [26] . The antibody test was conducted by SRL (Tokyo, Japan).
The Se gene has six alleles; Se1 (357C, 385A, 571C, and 628C), Se2 (357T, 385A, 571C, and 628C), sej (357T, 385T, 571C, and 628C), se3 (357C, 385A, 571T, and 628C), se4 (357C, 385A, 571C, and 628T), and se5 (conversion with pseudogene). Because both Se1 and Se2 have full enzyme activity, and se3 and se4 are very rare (0% out of 800 alleles) for Japanese [20] , the genotyping was conducted to distinguish A385T for sej and the pseudogene for se5 from Se (Se1 and Se2) by means of a related duplex polymerase chain reaction with confronting two-pair primers (PCR-CTPP) method [27, 28] . The primers were as follows; se5 F0, 5Ј-TTT CAC TGC CAC CAG CAC CTG; Se385 F1, 5Ј-ATC AAA GGC ACT GGG ACC CAG; Se385 R1, 5Ј-GGA CGT ACT CCC CCG GGA T; sej F2, 5Ј-TGG AGG AGG AAT ACC GCC ACT; sej R2, 5Ј-GTC CCC TCG GCG AAC ATG G. The underlined letters are the bases for the A385T polymorphism, and the primer se5F0 was set for the pseudogene. Genomic DNA (30-100 ng) was used for each 25-µl reaction mixture, 0.18 mM dNTPs, 12.5 pmol each of the five primers, 2.5 µl glycerol, 0.5 units of AmpliTaq Gold, 2.5 µl GeneAmp 10ϫ PCR buffer containing 15 mM MgCl 2 (Perkin-Elmer, Foster City, CA, USA). PCR conditions were 10 min of initial denaturation at 95°C, followed by 35 cycles of 1 min at 95°C, 1 min at 61°C, and 1 min at 72°C, and a 5-min final extension at 72°C. Amplified DNA was visualized on a 2% agarose gel containing ethidium bromide. The amplified band with 284 bp, 216 bp, and 353 bp represents the Se allele (385A), sej (385T), and se5 allele, respectively, while a common band of 460 bp appeared for the Se and sej alleles, as demonstrated in Fig. 1a .
The Le gene has four alleles; Le (59T, 508G, and 1067T), le1 (59G, 508A, and 1067T), le2 (59G, 508G, and 1067A), and le3 (59G, 508G, and 1067T). Because le3 is very rare (0.5% out of 800 alleles) for Japanese [20] , T59G was genotyped to distinguish le1 and le2 from Le by PCR-CTPP. The primers were: F1, 5Ј-CCA TGG ATC CCC TGG GTG; R1, 5Ј-CCA CCA GCA GCT GAA ATA GCC; F2, 5Ј-CGC TGT CTG GCC GCA CT; and R2, 5Ј-GAA GGT GGG AGG CGT GAC TTA. Genomic DNA (30-100 ng) was used for each 25-µl reaction with 0.18 mM dNTPs, 25 pmol each of the primers, 0.5 units of AmpliTaq Gold, and 2.5 µl GeneAmp 10ϫ PCR buffer containing 15 mM MgCl 2 (Perkin-Elmer). The PCR conditions were same as those for the Se genotyping, except for annealing at 66°C. Amplified were a 329-bp band for the T allele (Le) and an 81-bp band for the G allele (le1 and le2), while a common band of 373 bp appeared for both alleles (Fig. 1b) .
The present study had been approved by the Ethics Committee at Aichi Cancer Center before the study started (Ethics Committee Approval Numbers 41-2 and 11-12).
Statistical analysis
An unconditional logistic model was applied for estimating odds ratios (ORs), using a computer program (STATA version 7; STATA, College Station, TX, USA). ORs were adjusted for age as a dichotomous variable (Ͻ50 years vs Ն50 years). Goodness-of-fit of genotype distribution to Hardy-Weinberg equilibrium was examined by the "genhwi" procedure of STATA. Table 1 shows anti-H. pylori IgG seropositivity according to sex and age group for FVO and HCE subjects. The ages ranged from 18 to 79 years for the FVO and from 32 to 85 years for the HCE subjects. The seropositivity increased with age, and leveled off around age 50 years for both groups of subjects. The age-specific rate for men was slightly higher or equal to that for women, except for the 18-to-29-year-olds in the FVO group and the 30-to-39-year-olds in the HCE group.
Results
The percentages of self-reported current smokers at study entry were 35.9% in men and 13.2% in women in the FVO group, and 38.6% in men and 5.6% in women in the HCE group. The seroprevalence of anti-H. pylori antibody in the male FVO group was 59.3% for current smokers (n ϭ 113), 61.0% for former smokers (n ϭ 136), and 62.1 for never smokers (n ϭ 66); and in the female FVO group, the seroprevalences were 45.8% (n ϭ 48), 53.3% (n ϭ 30), and 46.7% (n ϭ 285), respectively. The corresponding prevalences in the HCE group were 59.2% (n ϭ 49), 85.7% (n ϭ 7), and 69.9% (n ϭ 71) for men; and 42.1% (n ϭ 19); 20.0% (n ϭ 5), and 51.6% (n ϭ 314) for women. The difference in H. pylori seroprevalence between current smokers and never smokers was not statistically significant for either sex according to subject group by a 2 test. The Se genotype was determined for all subjects, except for 1 HCE subject, and the Le genotype was determined for 663 (97.6%) of the 679 FVO subjects and 424 (91.2%) of the 465 HCE subjects. The genotype frequencies of each polymorphism are shown in Table 3 shows the sex-and-age-adjusted ORs for H. pylori seropositivity by study population. The OR for FVO subjects with the se allele (Sese or sese) was significantly higher than that for those with SeSe, and the adjusted OR for HCE subjects with Sese was marginally significant (95% confidence interval, 1.00-2.46). The Le genotype showed no significant association with seropositivity for either study population.
We also estimated ORs for H. pylori seropositivity according to risk groups created based on the results of our previous study [11] ; low-risk (sese & LeLe), moderate risk (combinations other than low-or high-risk groups), and high-risk (SeSe & lele, SeSe & Lele, and Sese & lele) groups. In the present study, no statistically significant association was observed between the combined genotype risk group and H. pylori seropositivity.
Discussion
This study did not reproduced the association of H. pylori seropositivity with the Se and Le polymorphisms observed in the preceding study of 239 outpatients (118 males and 121 females) who underwent gastroscopy at the Gastroenterology Clinic (OGC) of Aichi Cancer Center Hospital [11] . The subjects of the previous study included 95 (39.7% of 239) participants who stated that they were taking medication for diseases (not confirmed by their medical records); 23 subjects were taking medication for gastric/duodenal ulcer, another 23 for socalled gastritis, and 59 for miscellaneous diseases or conditions (i.e., some subjects were taking medication for more than one disease; no. of diseases ϭ 105). The H. pylori seropositivity was 72.1% for SeSe, 64.6% for ) . Even when the 23 ulcer patients and 23 gastritis patients were excluded, a strong association was observed (the ORs became larger). The observed association was consistent with a biologically plausible hypothesis described in the "Introduction" in this article. The lack of or the opposite associations observed for individuals in the same geographic area as those in the previous study [11] were a surprise to us. We expected that such associations with genetic polymorphisms would be consistent within one ethnic group, especially in the same geographic area. For example, we observed consistent associations between H. pylori seropositivity and the IL-1B C-31T polymorphism among Japanese in three datasets [12, 13, 29] , between the Dopamine Receptor D2 polymorphism and smoking habit in two datasets [30, 31] , and between the IL-1B C-31T polymorphism and smoking habit in two datasets [25] .
In epidemiologic studies of genetic polymorphisms and disease risk, inconsistent results are not rare among ethnically and/or geographically diverse groups even after eliminating the possibilities of various biases. Confounding by race/ethnicity, also known as population stratification, is a well-recognized phenomenon observed in a study that includes subjects from different ethnic groups. Inconsistent findings could result from other factors, such as random errors, unknown effect modification, dilution of the association strength, and their combinations. We discuss below these potential explanations for the inconsistency observed among three studies conducted in Aichi, Japan.
The first potential explanation is random error. Our previous study for OGC had 239 subjects, including 90 seronegative individuals. Seventeen of 61 subjects with SeSe and 4 of 17 subjects with lele were seronegative. The main purpose of the present study was to confirm the promising finding of the previous study [11] , using 527 seronegative and 617 seropositive subjects (in total 1144) sampled from the FVO and HCE groups. Because the 95% confidence interval of the OR for the high-risk group of OGC did not overlap with those observed in the present study, a random error may be not the cause of the inconsistent results. The present study with larger sample size should provide statistically more stable results than our previous study of OGC, if there were neither effect modifiers nor different degrees of dilution.
The second possibility is unknown effect modification, or interaction between risk factors (genetic or environmental). Gene-gene interactions and geneenvironment interactions have been documented for several diseases [32] [33] [34] [35] . We observed that smoking habit was not associated with H. pylori seropositivity in FVO [29] and HCE subjects [13] , while it was associated with the seropositivity in OGC subjects [12] . Although there is a controversy concerning the association between H. pylori infection and smoking habit [36] , the inconsistent results on smoking seem to be due to an effect modification; the association tends to be stronger for patients with gastrointestinal complaints than for healthy residents; stronger in high-prevalence than in low-prevalence areas; and stronger in populations with a high smoking prevalence than in populations with a low smoking prevalence [37] . In this study, the sese genotype percentages (26.7% in the 679 FVO subjects and 23.1% in the 464 HCE subjects) were similar to or slightly higher than those observed for Japanese in other areas (24.8% of 141 subjects [22] , 21.3% of 231 subjects [11] , and 18.5 of 400 subjects [20] ), and the lele genotype percentages (8.9% of 663 FVO subjects and 7.8% of 424 HCE subjects) were also similar to those in other studies (10.0% of 400 subjects [20] and 7.1% of 239 subjects [11] ). The association between H. pylori seropositivity and Se and Le polymorphisms, however, may be modified by unknown factors. Dilution of the association occurs when subjects whose outcome under study is not associated with risk factors of interest (e.g., those whose seropositivity is not influenced by Se and Le genotypes) are mixed with subjects for whom the outcome and risk factors are associated. An overall OR for the whole study population would become closer to unity (i.e., null association) with an increased proportion of subjects in the former group.
In the present study, there was no information on the mixture of individuals whose H. pylori seropositivity was not associated with the Se and Le genotypes. However, it is possible that H. pylori with BabA might be more prevalent in OGC than in FVO and HCE subjects. Because H type I and Le b antigens play a role in the attachment of BabA-positive H. pylori to gastric epithelial cells [18, 19] , the Se and Le genotypes do not influence the susceptibility for those with BabA-negative H. pylori. If BabA-positive H. pylori was associated with the hospital visit of H. pylori infected individuals due to severe gastritis [38] , the marked association observed only for OGC would be explained. In Japan, the BabA2 gene encoding BabA was reportedly highly prevalent (84.9% of 152 strains) in patients who underwent gastroscopy [39] , but no data are available for healthy residents. We could not examine for this hypothetical possibility, because H. pylori samples from our subjects were not available.
In summary, the association between H. pylori seropositivity and functional polymorphisms of Se and Le was not reproduced in the present study of 679 first-visit outpatients and 465 health checkup examinees. Because the association is biologically plausible, the inconsistent findings observed for the same ethnic group in the same geographic area may be due to unknown effect modification and/or dilution of association strength, although they could be due to other types of bias. Like other inconsistent findings observed for polymorphisms and disease risk, potential effect modifiers remain to be identified. Inconsistent findings are often unreported, but we believe it is important to report them to reduce the chance of reaching wrong conclusions due to publication bias.
